An article from 8VC points to LumineticsCore® as proof that AI in healthcare is advancing, while today’s reimbursement systems struggle to keep pace.
“Digital Diagnostics’ LumineticsCore is an AI system that conducts diabetic retinopathy screening using an autonomous AI model. The FDA [cleared] the model in 2018 but it took three years of discussion from that point to assign a billing code and determine an appropriate framework for pricing the code.”